08048036315
Cancer TEMOSIDE 250mg Capsules trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

TEMOSIDE 250 mg Capsules contain Temozolomide 250 mg and belong to the antineoplastic/alkylating-agent class of medicines. Temozolomide is used in the management of certain malignant brain tumors, including glioblastoma and anaplastic astrocytoma.

Phoenix Exim is described in your requested marketing context as a medicine exporter from Nagpur, India, supplying pharmaceutical products to markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable import regulations and prescription requirements.

2. Product Information

  • Brand: Temoside 250 mg Capsules
  • Active ingredient: Temozolomide
  • Strength: 250 mg
  • Dosage form: Oral capsule
  • Therapeutic category: Antineoplastic / anticancer medicine
  • Drug class: Alkylating agent
  • Manufacturer/marketer reported for Temoside: Cipla Ltd.
  • Storage: Store below 30°C, according to listed product information.

3. Uses of Temoside 250 mg

Temoside is prescribed for certain types of brain cancer. Temozolomide is indicated for newly diagnosed glioblastoma in adults in combination with radiotherapy followed by maintenance treatment, and for certain cases of anaplastic astrocytoma.

The exact treatment protocol depends on the patient's diagnosis, previous treatment, blood counts, overall health, and oncologist's treatment plan.

4. Benefits of This Medicine

When appropriately prescribed, temozolomide may:

  • Help slow or stop the growth of certain brain tumor cells.
  • Help control tumor progression.
  • Be used alongside radiotherapy in newly diagnosed glioblastoma.
  • Provide an oral chemotherapy option for eligible patients.
  • Be incorporated into treatment plans for certain recurrent or refractory brain tumors.

These are treatment benefits, not guaranteed outcomes, and response varies between patients.

5. Side Effects of Temoside 250 mg

Because temozolomide is chemotherapy, it can cause significant adverse effects. It may suppress bone marrow and reduce blood-cell counts, increasing the risk of infections or bleeding. Regular medical monitoring is therefore important.

Seek urgent medical attention for symptoms such as high fever, unusual bleeding or bruising, severe allergic reactions, or other serious symptoms.

6. Common Side Effects

Commonly reported side effects include:

  • Nausea
  • Vomiting
  • Fatigue or weakness
  • Headache
  • Constipation
  • Loss of appetite
  • Hair loss
  • Diarrhea
  • Dizziness
  • Low white blood-cell counts
  • Low platelet counts
  • Increased susceptibility to infections

7. How to Use

Take TEMOSIDE 250 mg exactly according to the oncologist's prescription. Treatment is generally given according to specific chemotherapy cycles rather than as a routine daily medicine indefinitely.

The capsule should be swallowed whole with water and should not be crushed, chewed, or opened. Product information commonly recommends taking temozolomide consistently on an empty stomach to help reduce nausea and maintain predictable absorption.

Do not change the dose, schedule, or duration yourself. If a dose is missed, contact the treating doctor or pharmacist for instructions rather than taking a double dose.

8. How Temoside 250 mg Works

Temozolomide is an alkylating agent. After administration, it forms an active compound that damages the DNA of rapidly dividing cancer cells. This DNA damage interferes with the cells' ability to replicate and divide, helping slow or stop tumor growth.

9. Safety Advice

  • Prescription use: Use only under specialist/oncologist supervision.
  • Blood counts: Regular blood tests may be required because treatment can reduce white blood cells and platelets.
  • Liver: Tell your doctor about liver disease or previous hepatitis B infection; liver monitoring may be required.
  • Kidneys: Inform your doctor about kidney problems before treatment.
  • Pregnancy: Temozolomide can harm an unborn baby and should not be used during pregnancy unless specifically directed by a specialist. Effective contraception is recommended according to medical advice.
  • Breastfeeding: Breastfeeding is generally not recommended during treatment because of potential harm to the infant.
  • Driving: Avoid driving or operating machinery if the medicine causes dizziness, sleepiness, fatigue, or reduced alertness.
  • Drug interactions: Tell your oncologist about all medicines, supplements, and treatments you are taking.
  • Handling: Follow the product's handling and disposal instructions carefully because this is a cytotoxic chemotherapy medicine.

10. Frequently Asked Questions

Q1. What is Temoside 250 mg used for?
It is used to treat certain brain cancers, particularly glioblastoma and certain forms of anaplastic astrocytoma, according to the prescribed treatment protocol.

Q2. What is the active ingredient in Temoside 250 mg?
The active ingredient is temozolomide 250 mg.

Q3. Is Temoside 250 mg a chemotherapy medicine?
Yes. Temozolomide is an oral chemotherapy medicine belonging to the alkylating-agent class.

Q4. Can I take Temoside without a prescription?
No. It is a prescription anticancer medicine and should only be taken under appropriate medical supervision.

Q5. Can Temoside cause low blood counts?
Yes. Bone-marrow suppression and reduced blood-cell counts are important potential adverse effects, which is why blood monitoring is commonly required.

Q6. Should Temoside be taken with food?
Follow your oncologist's instructions. Product information commonly recommends consistent administration on an empty stomach.

Q7. Can the capsule be crushed or opened?
It should generally be swallowed whole. Do not crush, chew, or open the capsule unless specifically instructed by a healthcare professional.

Q8. What should I do if I miss a dose?
Do not double the next dose. Contact your treating doctor or pharmacist for instructions.

11. Substitutes for Temoside 250 mg

Potential alternatives containing the same active ingredient, temozolomide 250 mg, include products such as Temodal 250 mg, Temcad 250 mg, Temoget 250 mg, Glotemoz 250 mg, and Axiotem 250 mg in some markets. Availability and regulatory status vary by country.

Important: A substitute should not be selected solely by brand name or price. The oncologist or pharmacist should confirm that the alternative has the correct active ingredient, strength, formulation, and approved indication.

12. SEO Keywords

Primary keywords:

  • Temoside 250 mg Capsules
  • Temoside 250 mg Capsule
  • Temozolomide 250 mg Capsules
  • Temozolomide 250 mg medicine
  • Temoside 250 mg exporter
  • Temoside 250 mg supplier
  • Temozolomide medicine exporter from India
  • Temoside 250 mg pharmaceutical exporter
  • Temoside 250 mg supplier from India
  • Temozolomide oncology medicine supplier

Long-tail B2B keywords:

  • Temoside 250 mg Capsules exporter from India
  • Temoside 250 mg Capsules supplier in India
  • Temozolomide 250 mg medicine exporter from Nagpur India
  • Temoside 250 mg pharmaceutical supplier from India
  • Temoside 250 mg oncology medicine exporter
  • Temozolomide 250 mg capsules wholesale supplier
  • Temozolomide 250 mg oncology medicine supplier India
  • Temoside 250 mg capsules for international pharmaceutical supply
  • Genuine Temoside 250 mg Capsules supplier India
  • Temoside 250 mg medicine exporter to USA
  • Temoside 250 mg medicine exporter to UK
  • Temoside 250 mg medicine exporter to Australia
  • Temoside 250 mg medicine exporter to Singapore
  • Temoside 250 mg medicine exporter to Canada
  • Temoside 250 mg medicine exporter to South Korea
  • Temoside 250 mg medicine exporter to UAE
  • Temozolomide 250 mg pharmaceutical exporter Nagpur
  • Phoenix Exim Temoside 250 mg supplier
  • Phoenix Exim temozolomide medicine exporter
  • Temozolomide oncology pharmaceutical supplier from Nagpur India
Aug 21st, 2026 3:27 PM

Keywords